| |
Age |
Chief complaint |
Ann Arbor Stage |
Histology |
Treatment |
Outcome |
| 1 |
77 |
Uterine prolapse |
IAE |
MZL |
Vaginal hysterectomy |
CR |
| 2 |
47 |
Brown discharge |
IIEB |
DLBCL |
R-CHOP |
CR |
| 3 |
72 |
Abdominal fullness |
IV |
DLBCL |
TC, TAH, R-THP-COP |
CR for 3 years |
| 4 |
85 |
Postmenopausal bleeding |
IE |
DLBCL |
R-CHOP |
Death in 5 months |
| 5 |
48 |
Irregular bleeding |
not stated |
NK Cell |
Chemotherapy not specified |
Death in 5 months |
| 6 |
36 |
Intermittent bleeding |
IB |
NK Cell |
CHOP |
Death |
| 7 |
49 |
Abdominal fullness |
IEA |
DLBCL |
R-CHOP, Radiation |
CR for 20 months |
| 51 |
Abdominal pain |
IIEA |
DLBCL |
R-CHOP, Radiation |
CR for 19 months |
| 8 |
79 |
Urinary obstruction |
not stated |
DLBCL |
R-CHOP |
Death in 9 months |
| 9 |
58 |
Abdominal mass |
not stated |
Burkitt |
TAH, BSO, Appendectomy PALD, PLD, Chemotherapy* |
CR 41 months |
|
*Vincristine, rituximab, high-dose mothotrexate with leucovorin/rescue, and intrathecal methotraxate
BSO: Bilateral Salphingo-oophrectomy; CR: Complete Remission; DLBLC:Diffuse Large B Cell Lymphoma; NK: Natural Killer; PALD: Para-Aortic Lymph Node Dissection; PLD: Pelvic Lymph Node Dissection; R-CHOP: Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; R-THP-COP: Rituximab, pirarubicin, cyclophosphamide, vincristine and prednisone; TAH: Total Abdominal Hysterectomy; TC: Paclitaxel and Carboplatin |
| Table 1: Case reports of primary uterine lymphoma published in the past five years. The numbers 1-9 correspond to reference number 5-13 in that ord er. |
